Robotic Versus Open Liver Resection in Hepatocarcinoma: Surgical and Oncological Outcomes.


Journal

Surgical laparoscopy, endoscopy & percutaneous techniques
ISSN: 1534-4908
Titre abrégé: Surg Laparosc Endosc Percutan Tech
Pays: United States
ID NLM: 100888751

Informations de publication

Date de publication:
21 Jan 2021
Historique:
received: 22 12 2019
accepted: 19 11 2020
pubmed: 23 1 2021
medline: 25 11 2021
entrez: 22 1 2021
Statut: epublish

Résumé

Minimally invasive approaches are spreading in every field of surgery, including liver surgery. However, studies comparing robotic hepatectomy with the conventional open approach regarding oncologic outcomes for hepatocellular carcinoma are limited. We retrospectively reviewed demographics characteristics, pathologic features, surgical, and oncological outcomes of patients who underwent robotic and conventional open liver resection for hepatocellular carcinoma. No significant differences in demographics features, tumor size, tumor location, and type of liver resection were found. The morbidity rate was similar, 23% for the open group versus 17% of the robotic group (P=0.605). Perioperative data analysis showed a greater estimated blood loss in patients who underwent open resection, if compared with robotic group (P=0.003). R0 resection and disease-free resection margins showed no statistically significant differences. The 3-year disease-free survival of the robotic group was comparable with that of the open group (54% vs. 37%; P=0.592), as was the 3-year overall survival (87% vs. 78%; P=0.203). The surgical and the oncological outcomes seem to be comparable between minimally invasive and open hepatectomy. Robotic liver resections are effective, and do not compromise the oncological outcome, representing a reasonable alternative to the open approach.

Sections du résumé

BACKGROUND BACKGROUND
Minimally invasive approaches are spreading in every field of surgery, including liver surgery. However, studies comparing robotic hepatectomy with the conventional open approach regarding oncologic outcomes for hepatocellular carcinoma are limited.
MATERIALS AND METHODS METHODS
We retrospectively reviewed demographics characteristics, pathologic features, surgical, and oncological outcomes of patients who underwent robotic and conventional open liver resection for hepatocellular carcinoma.
RESULTS RESULTS
No significant differences in demographics features, tumor size, tumor location, and type of liver resection were found. The morbidity rate was similar, 23% for the open group versus 17% of the robotic group (P=0.605). Perioperative data analysis showed a greater estimated blood loss in patients who underwent open resection, if compared with robotic group (P=0.003). R0 resection and disease-free resection margins showed no statistically significant differences. The 3-year disease-free survival of the robotic group was comparable with that of the open group (54% vs. 37%; P=0.592), as was the 3-year overall survival (87% vs. 78%; P=0.203).
CONCLUSIONS CONCLUSIONS
The surgical and the oncological outcomes seem to be comparable between minimally invasive and open hepatectomy. Robotic liver resections are effective, and do not compromise the oncological outcome, representing a reasonable alternative to the open approach.

Identifiants

pubmed: 33480668
doi: 10.1097/SLE.0000000000000904
pii: 00129689-202108000-00017
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

468-474

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350:2050–2059.
Guillou PJ, Quirke P, Thorpe H, et al. MRC CLASICC Trial Group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASPCC trial): multicentre, randomized controlled trial. Lancet. 2005;36:1718–1726.
Viganò L, Laurenzi A, Solbiati L, et al. Open liver resection, laparoscopic liver resection, and percutaneous thermal ablation for patients with solitary small hepatocellular carcinoma (≤30 mm): review of the literature and proposal for a therapeutic strategy. Dig Surg. 2018;35:359–371.
Jayne DG, Guillou PJ, Thorpe H, et al. UK MRC CLASICC Trial Group. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007;25:3061–3068.
Wakabayashi G, Cherqui D, Geller DA, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg. 2015;261:619–629.
Giulianotti PC, Coratti A, Sbrana F, et al. Robotic liver surgery: results for 70 resections. Surgery. 2011;149:29–39.
Idrees K, Bartlett DL. Robotic liver surgery. Surg Clin North Am. 2010;90:761–774.
Qiu J, Chen S, Chengyou D. A systematic review of robotic‐assisted liver resection and meta‐analysis of robotic versus laparoscopic hepatectomy for hepatic neoplasms. Surg Endosc. 2016;30:862–875.
Guerra F, Amore Bonapasta S, Annecchiarico M, et al. Robot‐integrated intraoperative ultrasound: initial experience with hepatic malignancies. Minim Invasive Ther Allied Technol. 2015;24:345–349.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. J Hepatol. 2018;69:182–236.
Child CG, Turcotte JG Child CG. Surgery and portal hypertension. The Liver and Portal Hypertension. Philadelphia, PA: W. B. Saunders Co; 1964:50.
Imamura H, Sano K, Sugawara Y, et al. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16–22.
Niehues SM, Unger JK, Malinowski M, et al. Liver volume measurement: reason of the difference between in vivo CT-volumetry and intraoperative ex vivo determination and how to cope it. Eur J Med Res. 2010;15:345–350.
Strasberg SM, Belghiti J, Clavien PA, et al. IHPBA Brisbane 2000 terminology of liver anatomy & resections. HPB. 2000;2:333–339.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.
Balzan S, Belghiti J, Farges O, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–828; discussion 828–829.
Wittekind C, Compton C, Quirke P, et al. A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status. Cancer. 2009;115:3483–3488.
Buell JF, Thomas MT, Rudich S, et al. Experience with more than 500 minimally invasive hepatic procedures. Ann Surg. 2008;248:475–486.
Buell JF, Thomas MJ, Doty TC, et al. An initial experience and evolution of laparoscopic hepatic resectional surgery. Surgery. 2004;136:804–811.
Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients. Ann Surg. 2009;250:831–841.
Giulianotti PC, Coratti A, Angelini M, et al. Robotics in general surgery: personal experience in a large community hospital. Arch Surg. 2003;138:777–784.
Salloum C, Lim C, Malek A, et al. Robot-assisted laparoscopic liver resection: a review. J Visc Surg. 2016;153:447–456.
Abood GJ, Tsung A. Robot-assisted surgery: improved tool for major liver resections? J Hepatobiliary Pancreat Sci. 2013;20:151–156.
Di Benedetto F, Ballarin R, Tarantino G. Totally robotic isolate caudate-lobe liver resection for hydatid disease: report of a case. Int J Med Robot. 2016;12:253–261.
Komatsu S, Brustia R, Goumard C, et al. Clinical impact of laparoscopic hepatectomy: technical and oncological viewpoints. Surg Endosc. 2017;31:1442–1450.
Casciola L, Patriti A, Ceccarelli G, et al. Robot-assisted parenchymal-sparing liver surgery including lesions located in the posterosuperior segments. Surg Endosc. 2011;25:3815–3824.
Patriti A, Ceccarelli G, Bartoli A, et al. Extracorporeal Pringle maneuver in robot-assisted liver surgery. Surg Laparosc Endosc Percutan Tech. 2011;21:e242–e244.
Pesi B, Moraldi L, Bartolini I, et al. Pringle maneuver in robotic liver surgery: preliminary study. Minerva Chir. 2018;73:482–487.
Morel P, Jung M, Cornateanu S, et al. Robotic versus open liver resections: a case-matched comparison. Int J Med Robot. 2017:13. doi: 10.1002/rcs.1800.
doi: 10.1002/rcs.1800
Sham JG, Richards MK, Seo YD, et al. Efficacy and cost of robotic hepatectomy: is the robotic cost-prohibitive? J Robot Surg. 2016;10:307–313.
Chen PD, Wu CY, Hu RH, et al. Robotic versus open hepatectomy for hepatocellular carcinoma: a matched comparison. Ann Surg Oncol. 2017;24:1021–1028.
Kingham TP, Leung U, Kuk D, et al. Robotic liver resection: a case-matched comparison. World J Surg. 2016;40:1422–1428.
Patriti A, Cipriani F, Ratti F, et al. Robotic-assisted versus open liver resection in the right posterior section. JSLS. 2014;18:1–6.
Daskalaki D, Gonzalez-Heredia R, Brown M, et al. Financial impact of the robotic approach in liver surgery: a comparative study of clinical outcomes and costs between the robotic and open technique in a single institution. J Laparoendosc Adv Surg Tech. 2017;27:375–382.
Buell JF, Cherqui D, Geller DA, et al. The international position on laparoscopic liver surgery: the Louisville Statement 2008. Ann Surg. 2009;250:825–830.
Giuliani A, Migliaccio C, Ceriello A, et al. Laparoscopic vs. open surgery for treating benign liver lesions: assessing quality of life in the first year after surgery. Updates Surg. 2014;66:127–133.
Memeo R, De’Angelis N, Compagnon P, et al. Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study. World J Surg. 2014;38:2919–2926.
Jackson NR, Hauch A, Hu T, et al. The safety and efficacy of approaches to liver resection: a meta-analysis. JSLS. 2015;19:e2014.00186.
Han DH, Choi SH, Park EJ, et al. Surgical outcomes after laparoscopic or robotic liver resection in hepatocellular carcinoma: a propensity-score matched analysis with conventional open liver resection. Int J Med Robot. 2016;12:735–742.
Croner RS, Perrakis A, Hohenberger W, et al. Robotic liver surgery for minor hepatic resections: a comparison with laparoscopic and open standard procedures. Langenbecks Arch Surg. 2016;401:707–714.
Montalti R, Berardi G, Patriti A, et al. Outcomes of robotic vs laparoscopic hepatectomy: a systematic review and meta-analysis. World J Gastroenterol. 2015;21:8441–8451.
Di Sandro S, Lauterio A, Giacomoni A, et al. Totally robotic liver resection for hepatocellular carcinoma in cirrhotic patients: safety and feasibility. J Robot Surg. 2014;8:357–364.
Lai E, Yang GC, Tang CN. Robotic-assisted laparoscopic liver resection for hepatocellular carcinoma: short-term outcome. Am J Surg. 2013;205:697–702.
Komatsu S, Brustia R, Goumard C, et al. Laparoscopic versus open major hepatectomy for hepatocellular carcinoma: a matched pair analysis. Surg Endosc. 2016;30:1965–1974.
Vitali GC, Laurent A, Terraz S, et al. Minimally invasive surgery versus percutaneous radio frequency ablation for the treatment of single small (3 cm) hepatocellular carcinoma: a case-control study. Surg Endosc. 2016;30:2301–2307.
Choi GH, Choi SH, Kim SH, et al. Robotic liver resection: technique and results of 30 consecutive procedures. Surg Endosc. 2012;26:2247–2258.
Berber E, Akyildiz HY, Aucejo F, et al. Robotic versus laparoscopic resection of liver tumours. HPB. 2010;12:583–586.
Tsung A, Geller DA, Sukato DC, et al. Robotic versus laparoscopic hepatectomy: a matched comparison. Ann Surg. 2014;259:549–555.

Auteurs

Benedetta Pesi (B)

Division of Oncological and Robotic General Surgery, Careggi University Hospital.

Lapo Bencini (L)

Division of Oncological and Robotic General Surgery, Careggi University Hospital.

Luca Moraldi (L)

Division of Oncological and Robotic General Surgery, Careggi University Hospital.

Federica Tofani (F)

Division of Oncological and Robotic General Surgery, Careggi University Hospital.

Giacomo Batignani (G)

Department of Surgery and Translational Medicine, Hepatobiliary Surgery Unit, University of Florence, Florence, Italy.

Paolo Bechi (P)

Department of Surgery and Translational Medicine, Hepatobiliary Surgery Unit, University of Florence, Florence, Italy.

Marco Farsi (M)

Division of Oncological and Robotic General Surgery, Careggi University Hospital.

Mario Annecchiarico (M)

Division of Oncological and Robotic General Surgery, Careggi University Hospital.

Andrea Coratti (A)

Division of Oncological and Robotic General Surgery, Careggi University Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH